Gilead Sciences (GILD) Return on Capital Employed Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
806.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
1,180.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
632.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-1,083.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
486.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
341.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-467.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
479.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
341.00 |
| Dec 31, 2025 |
1,763.00 |
| Sep 30, 2025 |
2,146.00 |
| Jun 30, 2025 |
1,214.00 |
| Mar 31, 2025 |
1,470.00 |
| Dec 31, 2024 |
-1,121.00 |
| Sep 30, 2024 |
-1,444.00 |
| Jun 30, 2024 |
-1,181.00 |
| Mar 31, 2024 |
-1,358.00 |
| Dec 31, 2023 |
72.00 |
| Sep 30, 2023 |
491.00 |
| Jun 30, 2023 |
456.00 |
| Mar 31, 2023 |
431.00 |
| Dec 31, 2022 |
-354.00 |
| Sep 30, 2022 |
-882.00 |
| Jun 30, 2022 |
-398.00 |
| Mar 31, 2022 |
486.00 |
| Dec 31, 2021 |
1,009.00 |
| Sep 30, 2021 |
1,516.00 |
| Jun 30, 2021 |
1,905.00 |
| Mar 31, 2021 |
-77.00 |
| Dec 31, 2020 |
-82.00 |
| Sep 30, 2020 |
-327.00 |
| Jun 30, 2020 |
-1,763.00 |
| Mar 31, 2020 |
-679.00 |
| Dec 31, 2019 |
-689.00 |
| Sep 30, 2019 |
-572.00 |
| Jun 30, 2019 |
-78.00 |
| Mar 31, 2019 |
-368.00 |
| Dec 31, 2018 |
-704.00 |
| Sep 30, 2018 |
-1,590.00 |
| Jun 30, 2018 |
-1,623.00 |
| Mar 31, 2018 |
-1,508.00 |
| Dec 31, 2017 |
-1,466.00 |
| Sep 30, 2017 |
-1,546.00 |
| Jun 30, 2017 |
-2,046.00 |
| Mar 31, 2017 |
-2,116.00 |
| Dec 31, 2016 |
-1,669.00 |
| Sep 30, 2016 |
-1,331.00 |
| Jun 30, 2016 |
-996.00 |
| Mar 31, 2016 |
-523.00 |
| Dec 31, 2015 |
-497.00 |
| Sep 30, 2015 |
820.00 |
| Jun 30, 2015 |
2,118.00 |
| Mar 31, 2015 |
2,683.00 |
| Dec 31, 2014 |
3,066.00 |
| Sep 30, 2014 |
2,549.00 |
| Jun 30, 2014 |
1,709.00 |
| Mar 31, 2014 |
941.00 |
| Dec 31, 2013 |
429.00 |
| Sep 30, 2013 |
145.00 |
| Jun 30, 2013 |
29.00 |
| Mar 31, 2013 |
-125.00 |
| Dec 31, 2012 |
-665.00 |
| Sep 30, 2012 |
-1,226.00 |
| Jun 30, 2012 |
-1,092.00 |
| Mar 31, 2012 |
-1,335.00 |
| Dec 31, 2011 |
-1,331.00 |
| Mar 31, 2011 |
-782.00 |
| Dec 31, 2010 |
-366.00 |
